Ravinder Singh

3PUBLICATIONS
13CO-AUTHORS
Epidemiological modellingPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Aug 02, 2024
Durability of Response With Selpercatinib in Patients With RET-Activated Thyroid Cancer: Long-Term Safety and Efficacy From LIBRETTO-001.

Lori J Wirth, Marcia S Brose, Vivek Subbiah

|Oct 23, 2023
Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer.

Julien Hadoux, Rossella Elisei, Marcia S Brose

Pageof 1